Ascendis Pharma A/S annual depreciation and amortization
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ascendis Pharma A/S Depreciation & Amortization Growth & History (ASND)
Ascendis Pharma A/S's depreciation and amortization was €17.2M for fiscal 2025.
View full Ascendis Pharma A/S company overviewAscendis Pharma A/S annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €17.2M | −€41,000 | −0.24% |
| 2024 | 2024-12-31 | €17.2M | −€1.2M | −6.41% |
| 2023 | 2023-12-31 | €18.4M | €914,000 | +5.22% |
| 2022 | 2022-12-31 | €17.5M | €2.6M | +17.18% |
| 2021 | 2021-12-31 | €14.9M | €5.5M | +58.19% |
| 2020 | 2020-12-31 | €9.4M | €2.8M | +41.27% |
| 2019 | 2019-12-31 | €6.7M | €5.8M | +660.00% |
| 2018 | 2018-12-31 | €880,000 | €146,000 | +19.89% |
| 2017 | 2017-12-31 | €734,000 | €57,000 | +8.42% |
| 2016 | 2016-12-31 | €677,000 | €119,000 | +21.33% |
| 2015 | 2015-12-31 | €558,000 | — | — |
Ascendis Pharma A/S quarterly depreciation and amortization
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €4.6M | €261,000 | +6.06% |
| Q1 2026 | 2026-03-31 | €4.2M | −€325,000 | −7.15% |
| Q4 2025 | 2025-12-31 | €4.8M | — | — |
| Q3 2025 | 2025-09-30 | €4.0M | — | — |
| Q2 2025 | 2025-06-30 | €4.3M | — | — |
| Q1 2025 | 2025-03-31 | €4.5M | — | — |
Ascendis Pharma A/S depreciation and amortization trends
Over the last five fiscal years, Ascendis Pharma A/S's depreciation and amortization increased from €9.4M to €17.2M, a change of €7.8M. The latest reported quarter, Q2 2026, shows €4.6M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ascendis Pharma A/S source filings ↗